Literature DB >> 6463196

Systemic lupus erythematosus with membranous lupus nephropathy in Malaysian patients.

F Wang, L M Looi.   

Abstract

Thirty-one patients with systemic lupus erythematosus had membranous lupus nephropathy (MLN). They were divided into two groups. Group I consisted of 13 patients who had pure MLN but the patients in Group 2 had segmental proliferation in up to 35 per cent of their glomeruli. The rest of the glomeruli had purely membranous change. The patients of Group 2 were no different from the other MLN patients in terms of age, sex and race. The extrarenal disease in both groups was extensive and severe. The renal disease was usually associated with the nephrotic syndrome or oedema but was asymptomatic throughout in one patient. Both renal and extrarenal features responded to treatment initially but relapses were frequent and often severe. Relapses often occurred as treatment was discontinued or medication reduced. Survival at six years in Group I was 62 per cent and in Group 2 was 50 per cent. Only one patient died with renal failure although five patients had impaired renal function at death. The chief causes of death were disease of the central nervous system and infection.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6463196

Source DB:  PubMed          Journal:  Q J Med        ISSN: 0033-5622


  8 in total

1.  Lupus nephritis: more answers needed.

Authors:  F Wang
Journal:  J R Soc Med       Date:  1985-08       Impact factor: 5.344

2.  Immunosuppressive treatment for pure membranous lupus nephropathy in a Hispanic population.

Authors:  Juan Manuel Mejía-Vilet; Bertha M Córdova-Sánchez; Norma O Uribe-Uribe; Ricardo Correa-Rotter
Journal:  Clin Rheumatol       Date:  2016-07-30       Impact factor: 2.980

3.  Anticardiolipin antibodies in patients from Malaysia with systemic lupus erythematosus.

Authors:  H W Jones; R Ireland; G Senaldi; F Wang; M Khamashta; A J Bellingham; K Veerapan; G R Hughes; D Vergani
Journal:  Ann Rheum Dis       Date:  1991-03       Impact factor: 19.103

Review 4.  The treatment of lupus nephritis.

Authors:  J S Cameron
Journal:  Pediatr Nephrol       Date:  1989-07       Impact factor: 3.714

5.  Thyroid disorders in systemic lupus erythematosus.

Authors:  K L Goh; F Wang
Journal:  Ann Rheum Dis       Date:  1986-07       Impact factor: 19.103

Review 6.  Lupus nephritis in childhood and adolescence.

Authors:  J S Cameron
Journal:  Pediatr Nephrol       Date:  1994-04       Impact factor: 3.714

7.  Comparison of Outcomes between Individuals with Pure and Mixed Lupus Nephritis: A Retrospective Study.

Authors:  Titilayo O Ilori; Nosayaba Enofe; Anju Oommen; Jason Cobb; Jose Navarrete; Demilade A Adedinsewo; Oluwatobiloba Oshikoya; Helene Fevrier; Alton B Farris; Laura Plantinga; Akinlolu O Ojo
Journal:  PLoS One       Date:  2016-06-15       Impact factor: 3.240

Review 8.  Prevention of renal failure: the Malaysian experience.

Authors:  Lai Seong Hooi; Hin Seng Wong; Zaki Morad
Journal:  Kidney Int Suppl       Date:  2005-04       Impact factor: 10.545

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.